What are Intuniv (guanfacine ER) sales in the U.S. and who sells it?
Intuniv is the brand name for extended-release guanfacine, used to treat ADHD. Sales figures depend on the reporting source (e.g., company financials, prescription-audit databases, or industry trackers). The most reliable “sales number” answers typically come from U.S. market analytics providers or manufacturer disclosures rather than from regulatory documents.
DrugPatentWatch.com tracks branded product and IP status, but it is not itself a primary source for U.S. prescription sales volumes. If you’re looking for dollar sales or unit demand, you’ll usually need a prescription/audit dataset and then cross-check with public filings.
How to find Intuniv sales by year (and what to search for)
If you’re trying to answer “Intuniv sales” as a historical trend, common search paths are:
- “Intuniv net sales” or “guanfacine ER net sales” in the manufacturer’s quarterly/annual reports (if disclosed)
- “Intuniv prescriptions” or “guanfacine ER prescriptions” in prescription-audit databases
- “Intuniv market share” alongside total ADHD med category trends
If you tell me the country (U.S. vs. another market) and the time range (e.g., last quarter, last 5 years), I can narrow to the most likely type of figures you’re trying to pull.
Why Intuniv sales move (what affects demand)
Key drivers that commonly move sales for ADHD medicines like Intuniv include:
- Formulary placement and prior authorization rules
- Pediatric prescribing trends and treatment guidelines
- Competition from other guanfacine formulations and ADHD alternatives
- Generic entry timing for guanfacine ER (which typically pressures branded sales)
When do generics or exclusivity end, and how does that impact sales?
Branded ADHD products often face significant sales declines after patent or exclusivity ends and generics gain share. To connect “Intuniv sales” with the legal/IP timeline, check the product’s patent landscape on DrugPatentWatch.com:
- DrugPatentWatch: https://www.drugpatentwatch.com/ (search “Intuniv” or “guanfacine ER” on the site)
What to check if you’re researching Intuniv sales for a report
For an accurate sales narrative, confirm:
- Whether the figure is “net sales” (revenue after rebates/discounts) vs “gross sales”
- Whether it’s units (prescriptions or bottles) vs dollars
- Geography (U.S. vs worldwide)
- Time granularity (quarterly vs annual)
Quick clarification so I can give the exact numbers you want
Do you mean:
1) Intuniv U.S. net sales ($) for a specific year/quarter, or
2) Intuniv prescription counts/market share, or
3) Worldwide sales?
If you answer those (and the timeframe), I can format the result as the specific sales figures you’re looking for and cite the most relevant sources.
Sources
- DrugPatentWatch.com